Prof. Günther Deuschl, President of the EAN, also welcomed everybody. He highlighted some recent important studies published by European researchers, the celebration of the Brain Prize in Europe, and some EAN achievements such as the guidelines project. The EAN is also particularly interested in assessing the burden of neurological diseases in Europe.
Category
Top Articles
-
-
Breaking newsResearchTop Articles
Breaking news: A new gene accounting for Parkinson’s disease and Dementia with Lewy Bodies
June 17, 2018An international research team led by Prof Vincenzo Bonifati (Department of Clinical Genetics, Erasmus MC Rotterdam) has discovered for the first time variants in a gene linked to familial forms of Parkinson’s disease (PD), Parkinson’s disease Dementia (PDD), and Dementia… Continue Reading -
Recently, EAN held elections of the Scientific Panel Management groups. All Panel Members - institutional that are nominated by a national society, and individual - were invited to send in their applications. The Scientific Committee received altogether 163 applications, from 30 different countries (59 female and 104 male applicants).
-
EAN NewsEAN Congress newsTop Articles
Neurological News from Portugal VI: Neurosciences at the Campus of the Faculty of Medicine of the University of Lisbon
June 1, 2018The year of 1949 was a celebrating year for Neurosciences in Portugal, since our professor of Neurology Egas Moniz was awarded the Nobel Prize of Medicine and Physiology, an important recognition of his neuroscience research. This was a mark that very much inspired the interest of our medical school on neurosciences. -
Scientific plagiarism is defined as using or closely imitating scientific content from an original author without clear reference and/or authorization. Plagiarism can be complete or partial, in the original or translated version or limited to paraphrases of the original text. A textual repetition of one’s own work in subsequent submissions is considered self-plagiarism and should be avoided or at least accompanied by proper referencing to one’s prior work.
-
As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!
-
Sub-committee and working group chairs
Members of committees Are you eager to shape the future of Neurology in Europe in parallel to developing your professional standing and leadership skills? Following the formation of a new Executive Board of the EAN… Continue Reading -
EAN NewsEAN NewsTop Articles
Expression of interest to become Chair of the Education Committee or Chair of the Programme Committee
May 29, 2018Dear members of the EAN, following the election of 5 members of the EAN Executive Board in Lisbon this new Board will appoint the chair of the education committee and the chair of the program committee. We therefore solicit the… Continue Reading -
Breaking newsResearchTop Articles
Dystonia Europe 25th Anniversary Lunch in EU Parliament in Brussels
May 8, 2018The celebrations of the Dystonia Europe 25th annniversary kicked off with a special lunch event in the European Parliament on 12 April. The 65 guests were welcomed by the Finnish Member of the European Parliament (MEP) Ms. Merja Kyllönen. She… Continue Reading -
The democratic body of the European Academy of Neurology (EAN) is the assembly of delegates, which acts as the parliament of the EAN. This assembly meets once a year, usually on Saturday, during the annual meeting. The 4 major… Continue Reading
-
As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below! Rolf Fronczek, MD, PhD
Dept. of… Continue Reading -
EAN NewsEAN Congress newsTop Articles
Neurological News from Portugal V: A brief summary of Behavioral Neurology in Portugal
May 1, 2018Portugal has a long tradition in the study of behavioral disorders, dating back to the work of Egas Moniz and his attempt to improve some psychosis with psychosurgery. In the early 1970’s Antonio Damasio, who was taking his PhD… Continue Reading
-
Paper of the MonthEAN NewsTop ArticlesFeatured Slider
Paper of the month: Slowing disability progression in secondary progressive multiple sclerosis with siponimod
May 1, 2018For May 2018, we have selected: Kappos L, Bar-Or A, Cree BAC, et al., for the EXPAND Clinical Investigators. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomized, phase 3 study. Lancet Neurol 2018;391:1263-1273. Secondary progressive multiple sclerosis (SPMS) is characterized by a previous history of relapsing remitting MS (RRMS) and the continuous progression of disability over the years typically without relapses. -
Portugal is a country with a 900-year history: many remnants of past colonization by Celtics, Romans, and Arabians are still present. Unquestionably, the greater contribution of Portugal to the humanity have been the overseas navigations around the world, namely the discovery of the maritime way to India, the discovery of Brazil and of several Atlantic islands.
-
15. Colloquium Neurologicum Salzburg – Seltene Erkrankungen in der Neurologie (Rare Diseases in Neurology) May 24th – 25th 2018, Salzburg, Austria Main Topics: 1. National and global perspective of rare neurological diseases 2. Neurologic manifestations of systemic disorders 3. Rare… Continue Reading